BioCryst Pharmaceuticals
BCRX
#5122
Rank
โ‚น149.56 B
Marketcap
โ‚น603.00
Share price
-1.35%
Change (1 day)
-11.81%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): -โ‚น0.54 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.59 Billion. In 2024 the company made an earning of -โ‚น7.97 Billion, an increase over its 2023 earnings that were of -โ‚น20.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.54 Billion-93.33%
2024 -โ‚น7.97 Billion-61.56%
2023 -โ‚น20.74 Billion-7.43%
2022 -โ‚น22.4 Billion34.42%
2021 -โ‚น16.67 Billion-0.55%
2020 -โ‚น16.76 Billion67.88%
2019 -โ‚น9.98 Billion7.55%
2018 -โ‚น9.28 Billion53.92%
2017 -โ‚น6.03 Billion19.29%
2016 -โ‚น5.06 Billion28.19%
2015 -โ‚น3.95 Billion-4.8%
2014 -โ‚น4.15 Billion50.09%
2013 -โ‚น2.76 Billion-23.29%
2012 -โ‚น3.6 Billion-26.19%
2011 -โ‚น4.88 Billion54.78%
2010 -โ‚น3.15 Billion150.1%
2009 -โ‚น1.26 Billion-49.43%
2008 -โ‚น2.49 Billion14.07%
2007 -โ‚น2.19 Billion-49.31%
2006 -โ‚น4.31 Billion72.87%
2005 -โ‚น2.5 Billion22.08%
2004 -โ‚น2.05 Billion75.3%
2003 -โ‚น1.17 Billion-25.36%
2002 -โ‚น1.56 Billion225.05%
2001 -โ‚น0.48 Billion-56.6%
2000 -โ‚น1.11 Billion50.63%
1999 -โ‚น0.74 Billion38.05%
1998 -โ‚น0.54 Billion-52.46%
1997 -โ‚น1.12 Billion58.44%
1996 -โ‚น0.71 Billion-14.44%
1995 -โ‚น0.83 Billion28.57%
1994 -โ‚น0.65 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น905.96 B-149,503.05%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น854.35 B-140,993.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น23.12 Billion 3,711.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.39 B-495.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น34.36 B-5,767.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น23.49 Billion 3,772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.75 Billion 22.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น2.27 Billion 274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.14 B-2,598.11%๐Ÿ‡บ๐Ÿ‡ธ USA